Evidence map›Paper›PMID 35340589›Full record

ArticleSSM. Qualitative research in health2022

Ferdinand Uellner, Freda Röhr, Claudia Denkinger, Till Bärnighausen, Andreas Deckert, Aurelia Souares, Shannon A McMahon

Open access · goldAbstract read
In one paragraph

Article in SSM. Qualitative research in health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Ferdinand UellnerHeidelberg Institute of Global Health, University of Heidelberg, Im Neuenheimer Feld 130/3, Heidelberg, Germany.
Freda RöhrHeidelberg Institute of Global Health, University of Heidelberg, Im Neuenheimer Feld 130/3, Heidelberg, Germany.
Claudia DenkingerDivision of Clinical Tropical Medicine, Centre for Infectiology, Heidelberg University Hospital, Heidelberg, Germany.
Till BärnighausenHeidelberg Institute of Global Health, University of Heidelberg, Im Neuenheimer Feld 130/3, Heidelberg, Germany.
Andreas DeckertHeidelberg Institute of Global Health, University of Heidelberg, Im Neuenheimer Feld 130/3, Heidelberg, Germany.
Aurelia SouaresHeidelberg Institute of Global Health, University of Heidelberg, Im Neuenheimer Feld 130/3, Heidelberg, Germany.
Shannon A McMahonHeidelberg Institute of Global Health, University of Heidelberg, Im Neuenheimer Feld 130/3, Heidelberg, Germany.
Heidelberg University · DEGerman Center for Infection Research · DEUniversity Hospital Heidelberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although a majority of SARS-COV-2 diagnosis are asymptomatic, presymptimatic or minimally symptomatic, little has been described and understood about the illness careers of these individuals. This study explored the lived experience of a SARS-COV-2 diagnosis and subsequent quarantine among individuals in Germany who were diagnosed with SARS-COV-2 during the second wave of the pandemic (late 2020-early 2021), but whose diagnosis was unexpected due to a lack of a known contact, or the asymptomatic nature of their case at the time of diagnosis. In-depth interviews (n ​= ​22) were conducted by phone or video call, audio-recorded, and transcribed verbatim. Routine debriefings guided data collection and facilitated analysis, which followed a framework approach. Regardless of age, gender or socioeconomic status, data consistently demonstrated a diagnosis and quarantine career marked by five emotional phases: overconfidence, shock and denial, coming to grips and asking questions, enduring, and cautious optimism as quarantine ended. These experiences suggest that providing trustworthy, easily accessible information regarding certain key aspects of the post diagnosis and quarantine period could benefit patients in terms of reducing stress, understanding the consequences of a diagnosis and mitigating foreseeable challenges in terms of personal, logistical and emotional issues. Follow-up research with providers and public health bureaus could inform how to best tailor such messaging for clients who experience an unexpected diagnosis.

Indexed as

Asymptomatic experienceExperience stagesGermanyIn-depth-interviewSARS-COV-2

Identifiers

PMID35340589
PMCPMC8938303
OpenAlexW4220703917

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.